Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
International Journal of Cancer|February 8, 2013
Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancerGrace O'Callaghan, Aideen Ryan, Peter Neary, et al.The FEBS Journal|December 12, 2018
Engagement of Fas differentially regulates the production of LPS-induced proinflammatory cytokines and type I interferonsKiva Brennan, Caitriona Lyons, Philana Fernandes, et al.Bioelectrochemistry (Amsterdam, Netherlands)|February 28, 2026
Electrochemotherapy impacts the viability, functionality and phenotype of murine dendritic cells in voltage-dependent mannerMaura B Bendix, Kevin J Baker, Patrick F Forde, et al.International Journal of Cancer|July 11, 2007
Modulation of p21-activated kinase 1 alters the behavior of renal cell carcinomaGerald C O'Sullivan, Mark Tangney, Garret Casey, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2013
Identification of TLR10 as a key mediator of the inflammatory response to Listeria monocytogenes in intestinal epithelial cells and macrophagesTim Regan, Ken Nally, Ruaidhri Carmody, et al.Cytokine|March 17, 2023
IL-36 expression is increased in NSCLC with IL-36 stimulation of lung cancer cells promoting a pro-tumorigenic phenotypeKevin James Baker, Emily Buskiewicz, Méabh Finucane, et al.Prostaglandins & Other Lipid Mediators|February 1, 2020
The COX-2 inhibitor NS398 selectively sensitizes hypoxic HeLa cells to ionising radiation by mechanisms both dependent and independent of COX-2Shailendra Anoopkumar-Dukie, Tom Conere, Aileen Houston, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2014
Intestinal expression of Fas and Fas ligand is upregulated by bacterial signaling through TLR4 and TLR5, with activation of Fas modulating intestinal TLR-mediated inflammationPhilana Fernandes, Charlotte O'Donnell, Caitriona Lyons, et al.Oncogene|April 2, 2022
IL-36 signalling enhances a pro-tumorigenic phenotype in colon cancer cells with cancer cell growth restricted by administration of the IL-36R antagonistKevin Baker, Charlotte O'Donnell, Maura Bendix, et al.International Journal of Cancer|September 2, 2003
Fas ligand expressed in colon cancer is not associated with increased apoptosis of tumor cells in vivoAileen Houston, Frank D Waldron-Lynch, Michael W Bennett, et al.Pageof 3